Hematologic malignancies, as one group of common malignant tumors, is a big threat to human health.
血液肿瘤是威胁人类健康的常见恶性肿瘤之一。
Now several studies have indicated that TAM is related to the clinical manifestations and prognosis of hematologic malignancies.
目前多项研究表明TAM与血液系统恶性肿瘤的临床表现及预后相关。
Invasive fungal infection (ifi) is associated with significant morbidity and mortality in patients with hematologic malignancies.
侵袭性真菌感染(ifi)是导致恶性血液病患者发病和死亡的重要原因之一。
The plasma concentration of D-D was measured by enzyme-linked immunosorbent assay(ELISA) in 45 patients with hematologic malignancies.
采用酶联免疫吸附测定（ELISA）双抗夹心法对4 5例恶性血液病进行了D D测定。
Angiogenesis plays an important role in solid tumors and hematologic malignancies. The angiopoietins act as essential regulators in this process.
血管发生在实体肿瘤及血液系统恶性肿瘤进程中扮演重要角色。血管生成素是其重要的调节因素。
The expression and the signaling pathways of VEGF play an important role in the pathogenesis and clinical features of hematologic malignancies, in particular multiple myeloma.
VEGF的表达及其信号转导，对血液学恶性疾病，尤其是对多发性骨髓瘤的发病机制及临床特性都有重要作用。
In patients receiving lenalidomide maintenance therapy, hematologic second primary malignancies occurred in 7.5% of patients compared to 3.3% in patients receiving placebo.
接受来那度胺维持治疗的患者中，有7.5%出现了血液第二原发性恶性肿瘤，而接受安慰剂的患者中有3.3%。
In patients receiving lenalidomide maintenance therapy, hematologic second primary malignancies occurred in 7.5% of patients compared to 3.3% in patients receiving placebo.
接受来那度胺维持治疗的患者中，有7.5%出现了血液第二原发性恶性肿瘤，而接受安慰剂的患者中有3.3%。
应用推荐